Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review

Abstract

Keywords

pediatrics psoriatic arthritis psoriasis biologics etanercept adalimumab secukinumab

Get full access to this article

View all access options for this article.

References

Azuaga

A. B.

Ramírez

Cañete

J. D.

Psoriatic Arthritis: Pathogenesis and Targeted Therapies. Int J Mol Sci 24 (2023). https://doi.org/10.3390/ijms24054901

Coates

L. C.

Helliwell

P. S

. Psoriatic arthritis: state of the art review. Clin Med (Lond) 17, 65-70 (2017). https://doi.org/10.7861/clinmedicine.17-1-65

Brunello

, et al. New Insights on Juvenile Psoriatic Arthritis. Front Pediatr 10, 884727 (2022). https://doi.org/10.3389/fped.2022.884727

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.17 MB